Receipt of NASDAQ Delisting Determination Plans to Appeal
15 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Receipt of NASDAQ Delisting DeterminationPlans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products… Read More »Receipt of NASDAQ Delisting Determination Plans to Appeal